US4082819A
(en)
|
1977-03-02 |
1978-04-04 |
The Standard Oil Company |
Rubber-modified acrylonitrile-vinyl ether-indene polymers
|
JPS5663950A
(en)
|
1979-10-30 |
1981-05-30 |
Mitsubishi Chem Ind Ltd |
Cyclopropanecarboxylic ester
|
FR2535721A1
(fr)
|
1982-11-08 |
1984-05-11 |
Sanofi Sa |
Derives de la piperidinedione protecteurs du myocarde presentant une acticite antiarythmique, leur procede de preparation et les medicaments qui contiennent lesdits derives
|
US4911920A
(en)
|
1986-07-30 |
1990-03-27 |
Alcon Laboratories, Inc. |
Sustained release, comfort formulation for glaucoma therapy
|
JPS623848A
(ja)
|
1985-06-28 |
1987-01-09 |
Nippon Steel Corp |
疲労強度のすぐれたスタツド付きフラツシユバツト溶接アンカ−チエ−ン
|
FR2588189B1
(fr)
|
1985-10-03 |
1988-12-02 |
Merck Sharp & Dohme |
Composition pharmaceutique de type a transition de phase liquide-gel
|
JP2518353B2
(ja)
|
1988-06-09 |
1996-07-24 |
住友化学工業株式会社 |
シアノ酢酸アミド誘導体およびその製造中間体
|
CA2018801C
(fr)
|
1990-06-12 |
2000-08-22 |
Pierre Louis Beaulieu |
Derives peptidiques comprenant une terminaison-n1,4-dioxo-c4
|
JPH04177244A
(ja)
|
1990-11-10 |
1992-06-24 |
Konica Corp |
ハロゲン化銀写真感光材料
|
CA2033447C
(fr)
|
1990-12-31 |
1999-08-31 |
Robert Deziel |
Complexe synergique pour le traitement des infections herpetiques
|
DE69212850T2
(de)
|
1991-01-15 |
1997-03-06 |
Alcon Lab Inc |
Verwendung von Karrageenan in topischen ophthalmologischen Zusammensetzungen
|
US5212162A
(en)
|
1991-03-27 |
1993-05-18 |
Alcon Laboratories, Inc. |
Use of combinations gelling polysaccharides and finely divided drug carrier substrates in topical ophthalmic compositions
|
JPH05301838A
(ja)
|
1991-10-15 |
1993-11-16 |
Mitsubishi Kasei Corp |
スチレン誘導体
|
US5792771A
(en)
|
1992-11-13 |
1998-08-11 |
Sugen, Inc. |
Quinazoline compounds and compositions thereof for the treatment of disease
|
WO1995024190A2
(fr)
|
1994-03-07 |
1995-09-14 |
Sugen, Inc. |
Inhibiteurs de tyrosine-kinase receptrice destines a inhiber les troubles lies a la proliferation cellulaire et compositions les contenant
|
JPH0827090A
(ja)
|
1994-05-13 |
1996-01-30 |
Sumitomo Chem Co Ltd |
シアノ酢酸アミド誘導体、その用途およびその製造中間体
|
US6331555B1
(en)
|
1995-06-01 |
2001-12-18 |
University Of California |
Treatment of platelet derived growth factor related disorders such as cancers
|
PL335839A1
(en)
|
1997-03-14 |
2000-05-22 |
Basf Ag |
Cycloalkylalkane carboxamides as well as their production and application
|
US7863444B2
(en)
|
1997-03-19 |
2011-01-04 |
Abbott Laboratories |
4-aminopyrrolopyrimidines as kinase inhibitors
|
IL125947A0
(en)
|
1997-09-17 |
1999-04-11 |
American Cyanamid Co |
3-(1,2-benzisothiazol- and isoxazol-5-yl)-2,4(1h,3h)-pyrimidinedione or thione and 3-(1,2-benzisothiazol- and isoxazol-5-yl)-4(3)-pyrimidinone or thione herbicidal agents
|
PT1021171E
(pt)
|
1997-10-09 |
2003-10-31 |
Dexcel Pharma Technologies Ltd |
Sistema de administracao de farmacos no tracto gastrointestinal de libertacao total prolongada
|
US6713474B2
(en)
|
1998-09-18 |
2004-03-30 |
Abbott Gmbh & Co. Kg |
Pyrrolopyrimidines as therapeutic agents
|
RU2312860C2
(ru)
|
1999-04-15 |
2007-12-20 |
Бристол-Маерс Сквибб Компани |
Циклические ингибиторы протеинтирозинкиназ
|
IL148718A0
(en)
|
1999-09-17 |
2002-09-12 |
Abbott Gmbh & Co Kg |
Pyrazolopyrimidines as therapeutic agents
|
WO2001072751A1
(fr)
|
2000-03-29 |
2001-10-04 |
Knoll Gesellschaft Mit Beschraenkter Haftung |
Pyrrolopyrimidines utilisees comme inhibiteurs de tyrosine kinases
|
AR042586A1
(es)
|
2001-02-15 |
2005-06-29 |
Sugen Inc |
3-(4-amidopirrol-2-ilmetiliden)-2-indolinona como inhibidores de la protein quinasa; sus composiciones farmaceuticas; un metodo para la modulacion de la actividad catalitica de la proteinquinasa; un metodo para tratar o prevenir una afeccion relacionada con la proteinquinasa
|
MXPA03008560A
(es)
|
2001-03-22 |
2004-06-30 |
Abbot Gmbh & Co Kg |
Pirazolopirimidinas como agentes terapeuticos.
|
CA2465328C
(fr)
|
2001-11-01 |
2011-06-14 |
Michael Francis Gross |
Piperidines
|
JP3991812B2
(ja)
|
2001-12-11 |
2007-10-17 |
住友化学株式会社 |
エステル化合物およびその用途
|
AU2003210983A1
(en)
|
2002-02-11 |
2003-09-04 |
The Brigham And Women's Hospital, Inc. |
Kinase inhibitors and methods of use thereof
|
NI200300043A
(es)
|
2002-03-28 |
2003-11-05 |
Warner Lambert Co |
AMINOACIDOS CON AFINIDAD POR LA PROTEINA a2DELTA.
|
FR2842735B1
(fr)
|
2002-07-26 |
2006-01-06 |
Flamel Tech Sa |
Microcapsules a liberation modifiee de principes actifs peu solubles pour l'administration per os
|
GB0219024D0
(en)
|
2002-08-15 |
2002-09-25 |
Pfizer Ltd |
Synergistic combinations
|
US7419981B2
(en)
|
2002-08-15 |
2008-09-02 |
Pfizer Inc. |
Synergistic combinations of an alpha-2-delta ligand and a cGMP phosphodieterse 5 inhibitor
|
GB0226370D0
(en)
|
2002-11-12 |
2002-12-18 |
Novartis Ag |
Organic compounds
|
EP1597256A1
(fr)
|
2003-02-21 |
2005-11-23 |
Pfizer Inc. |
Derives d'amino-thiazole substitues par n-heterocyclyle en tant qu'inhibiteurs de la proteine kinase
|
US20050008640A1
(en)
|
2003-04-23 |
2005-01-13 |
Wendy Waegell |
Method of treating transplant rejection
|
ES2295930T3
(es)
|
2003-08-01 |
2008-04-16 |
Chugai Seiyaku Kabushiki Kaisha |
Compuestos de cianoamida utiles como inhibidores de malonil-coa descarboxilasa.
|
BRPI0414082A
(pt)
|
2003-09-02 |
2006-10-24 |
Pfizer Prod Inc |
formas de dosagem de liberação sustentada de ziprasidona
|
WO2005023773A1
(fr)
|
2003-09-04 |
2005-03-17 |
Pfizer Limited |
Procede pour la preparation d'arylpyrazoles substitues
|
GB0322140D0
(en)
|
2003-09-22 |
2003-10-22 |
Pfizer Ltd |
Combinations
|
KR100774625B1
(ko)
|
2003-09-25 |
2007-11-08 |
워너-램버트 캄파니 엘엘씨 |
치료제 베타 아미노산
|
CA2553724A1
(fr)
|
2004-02-03 |
2005-08-18 |
Abbott Laboratories |
Utilisation d'aminobenzoxazoles comme agents therapeutiques
|
JP4552456B2
(ja)
|
2004-02-27 |
2010-09-29 |
住友化学株式会社 |
エステル化合物およびその用途
|
EP1724264A1
(fr)
|
2004-03-10 |
2006-11-22 |
Ono Pharmaceutical Co., Ltd. |
Nitriles et compositions medicinales contenant ceux-ci en tant qu'ingredient actif
|
US7807719B2
(en)
|
2004-09-14 |
2010-10-05 |
Chaim Roifman |
Compounds useful for modulating abnormal cell proliferation
|
EP1794137A4
(fr)
|
2004-09-27 |
2009-12-02 |
Kosan Biosciences Inc |
Inhibiteurs de kinases specifiques
|
JP2008530113A
(ja)
|
2005-02-11 |
2008-08-07 |
コーリー ファーマシューティカル グループ,インコーポレイテッド |
オキシムおよびヒドロキシラミン置換イミダゾ[4,5−c]環化合物および方法
|
AU2006228525A1
(en)
|
2005-03-28 |
2006-10-05 |
Dexcel Pharma Technologies Ltd. |
Controlled absorption of statins in the intestine
|
BRPI0611187A2
(pt)
|
2005-06-03 |
2010-08-24 |
Xenon Pharmaceuticals Inc |
derivados aminotiazàis como inibidores da estearoil-coa desaturase humana
|
US20070149464A1
(en)
|
2005-06-15 |
2007-06-28 |
Pfizer Inc. |
Combination
|
US7645786B2
(en)
|
2005-06-15 |
2010-01-12 |
Pfizer Inc. |
Substituted arylpyrazoles
|
ES2338699T3
(es)
|
2005-06-15 |
2010-05-11 |
Pfizer Limited |
Arilpirazoles sustituidos para uso contra parasitos.
|
US20080176865A1
(en)
|
2005-06-15 |
2008-07-24 |
Pfizer Limited |
Substituted arylpyrazoles
|
US20080146643A1
(en)
|
2005-06-15 |
2008-06-19 |
Pfizer Limited |
Combination
|
GB0517205D0
(en)
|
2005-08-22 |
2005-09-28 |
Novartis Ag |
Organic compounds
|
JPWO2007043401A1
(ja)
|
2005-10-07 |
2009-04-16 |
キッセイ薬品工業株式会社 |
含窒素複素環化合物およびそれを含有する医薬組成物
|
WO2007064932A2
(fr)
|
2005-12-02 |
2007-06-07 |
Bayer Healthcare Llc. |
Dérivés de pyrrolotriazine utiles pour traiter le cancer par inhibition de la kinase aurora
|
MX2008008642A
(es)
|
2006-01-13 |
2008-09-12 |
Pharmacyclics Inc |
Inhibidores de las tirosina cinasas y usos de los mismos.
|
WO2007115269A2
(fr)
|
2006-03-31 |
2007-10-11 |
The Board Of Regents Of The University Of Texas System |
Médicaments anticancéreux biodisponibles par voie orale associés à l'acide caféique
|
US7645748B2
(en)
|
2006-04-03 |
2010-01-12 |
Forbes Medi-Tech Inc. |
Sterol/stanol phosphorylnitroderivatives and use thereof
|
CA2653941C
(fr)
|
2006-05-31 |
2013-01-08 |
The Regents Of The University Of California |
Derives d'aminopurine substitues et leurs utilisations
|
WO2008005954A2
(fr)
|
2006-06-30 |
2008-01-10 |
The Board Of Regents Of The University Of Texas System |
Modulateurs de protéine signal en tant qu'agents thérapeutiques
|
MY147628A
(en)
|
2006-07-06 |
2012-12-31 |
Array Biopharma Inc |
Cyclopenta [d] pyrimidines as akt protein kinase inhibitors
|
EP2081435B1
(fr)
|
2006-09-22 |
2016-05-04 |
Pharmacyclics LLC |
Inhibiteurs de la tyrosine kinase de bruton
|
CA2668286C
(fr)
|
2006-11-03 |
2014-09-16 |
Pharmacyclics, Inc. |
Sonde d'activite de la tyrosine kinase de bruton et son procede d'utilisation
|
CA2670143A1
(fr)
|
2006-11-23 |
2008-05-29 |
Novartis Ag |
Pyrimidines et leur utilisation comme antagonistes du recepteur cxcr2
|
EP2125819B1
(fr)
|
2007-03-21 |
2014-10-22 |
Bristol-Myers Squibb Company |
Composés hétérocycliques fusionnés utiles pour le traitement de maladies prolifératives, allergiques, auto-immunes ou inflammatoires
|
GB2447933A
(en)
|
2007-03-27 |
2008-10-01 |
Chemence Ltd |
Cyanoacrylate monomer for forming an adhesive polymer
|
EP2560007A1
(fr)
|
2007-03-28 |
2013-02-20 |
Pharmacyclics, Inc. |
Identification des Inhibiteurs de la tyrosine kinase de bruton
|
KR101261514B1
(ko)
|
2008-02-25 |
2013-05-07 |
에프. 호프만-라 로슈 아게 |
피롤로피라진 키나아제 저해제
|
ATE522536T1
(de)
|
2008-02-25 |
2011-09-15 |
Hoffmann La Roche |
Pyrrolopyrazin-kinasehemmer
|
WO2009140128A2
(fr)
|
2008-05-13 |
2009-11-19 |
Irm Llc |
Composés et compositions servant d'inhibiteurs de kinases
|
CA2724715A1
(fr)
|
2008-05-22 |
2009-11-26 |
Amgen Inc. |
Heterocycles en tant qu'inhibiteurs de proteine kinase
|
EP3311818A3
(fr)
|
2008-07-16 |
2018-07-18 |
Pharmacyclics, LLC |
Inhibiteurs de tyrosine-kinase de bruton pour le traitement de tumeurs solides
|
KR20110050654A
(ko)
|
2008-08-01 |
2011-05-16 |
바이오크리스트 파마수티컬즈, 인코퍼레이티드 |
Jak3 억제제로서의 피페리딘 유도체
|
US8450337B2
(en)
|
2008-09-30 |
2013-05-28 |
Moleculin, Llc |
Methods of treating skin disorders with caffeic acid analogs
|
US20120028981A1
(en)
|
2008-11-05 |
2012-02-02 |
Principia Biopharma Inc. |
Kinase Knockdown Via Electrophilically Enhanced Inhibitors
|
US20100113520A1
(en)
|
2008-11-05 |
2010-05-06 |
Principia Biopharma, Inc. |
Kinase knockdown via electrophilically enhanced inhibitors
|
US8426428B2
(en)
|
2008-12-05 |
2013-04-23 |
Principia Biopharma, Inc. |
EGFR kinase knockdown via electrophilically enhanced inhibitors
|
CA2773848A1
(fr)
|
2009-09-09 |
2011-03-17 |
Avila Therapeutics, Inc. |
Inhibiteurs de pi3 kinase et leurs utilisations
|
US7741330B1
(en)
|
2009-10-12 |
2010-06-22 |
Pharmacyclics, Inc. |
Pyrazolo-pyrimidine inhibitors of Bruton's tyrosine kinase
|
US20130035325A1
(en)
|
2009-11-16 |
2013-02-07 |
The Regents Of The University Of California |
Kinase inhibitors
|
BR112012029437A2
(pt)
|
2010-05-20 |
2017-03-07 |
F Hoffmann - La Roche Ag |
derivados de pirrolo[2,3-b]pirazina-7-carboxamida e seu uso como inibidores de jak e syk
|
MX2012013622A
(es)
|
2010-05-31 |
2013-02-01 |
Ono Pharmaceutical Co |
Derivado de purinona.
|
US20120071497A1
(en)
|
2010-06-03 |
2012-03-22 |
Pharmacyclics, Inc. |
Methods of treating abc-dlbcl using inhibitors of bruton's tyrosine kinase
|
WO2011153514A2
(fr)
|
2010-06-03 |
2011-12-08 |
Pharmacyclics, Inc. |
Utilisation d'inhibiteurs de la tyrosine kinase de bruton (btk)
|
CN101880243A
(zh)
|
2010-06-04 |
2010-11-10 |
贵阳柏丝特化工有限公司 |
一种含氟氰拟除虫菊酯化合物及其合成方法与用途
|
KR20130099040A
(ko)
|
2010-08-10 |
2013-09-05 |
셀진 아빌로믹스 리서치, 인코포레이티드 |
Btk 억제제의 베실레이트 염
|
US20140107151A1
(en)
|
2011-05-17 |
2014-04-17 |
Principia Biophama Inc. |
Tyrosine kinase inhibitors
|
DK2710007T3
(da)
|
2011-05-17 |
2020-01-27 |
Principia Biopharma Inc |
Kinasehæmmere
|
PL2710005T3
(pl)
|
2011-05-17 |
2017-07-31 |
Principia Biopharma Inc. |
Inhibitory kinazy tyrozynowej
|
US9376438B2
(en)
|
2011-05-17 |
2016-06-28 |
Principia Biopharma, Inc. |
Pyrazolopyrimidine derivatives as tyrosine kinase inhibitors
|
US8828426B2
(en)
|
2011-06-07 |
2014-09-09 |
Zx Pharma, Llc |
Multiparticulate L-carnitine compositions and related methods
|
BR112013033534A2
(pt)
|
2011-06-28 |
2017-02-07 |
Pharmacyclics Inc |
métodos e composições para inibição de reabsorção de osso
|
WO2013010136A2
(fr)
|
2011-07-13 |
2013-01-17 |
Pharmacyclics, Inc. |
Inhibiteurs de tyrosine kinase de bruton
|
WO2013010869A1
(fr)
|
2011-07-19 |
2013-01-24 |
Msd Oss B.V. |
4-imidazopyridazin-1-yl-benzamides et 4-imidazotriazin-1-yl-benzamides inhibiteurs de btk
|
EP2548877A1
(fr)
|
2011-07-19 |
2013-01-23 |
MSD Oss B.V. |
Dérivés de 4-(pyridine condensée à 5 chaînons)benzamide comme inhibiteurs de BTK
|
PE20141681A1
(es)
*
|
2011-07-19 |
2014-11-14 |
Merck Sharp And Dohme B V |
Inhibidores de btk
|
WO2013041605A1
(fr)
|
2011-09-20 |
2013-03-28 |
Cellzome Limited |
Dérivés de pyrazolo[4,3-c]pyridine comme inhibiteurs de kinases
|
KR20230109775A
(ko)
|
2011-10-19 |
2023-07-20 |
파마싸이클릭스 엘엘씨 |
브루톤 티로신 인산화효소(btk)의 억제제의 용도
|
US8377946B1
(en)
|
2011-12-30 |
2013-02-19 |
Pharmacyclics, Inc. |
Pyrazolo[3,4-d]pyrimidine and pyrrolo[2,3-d]pyrimidine compounds as kinase inhibitors
|
US8501724B1
(en)
|
2012-01-31 |
2013-08-06 |
Pharmacyclics, Inc. |
Purinone compounds as kinase inhibitors
|
EP2858500A4
(fr)
*
|
2012-06-08 |
2016-04-06 |
Biogen Ma Inc |
Inhibiteurs de la tyrosine kinase de bruton
|
US20160045503A1
(en)
|
2012-06-18 |
2016-02-18 |
Principia Biopharma Inc. |
Formulations containing reversible covalent compounds
|
WO2014004707A1
(fr)
|
2012-06-29 |
2014-01-03 |
Principia Biopharma Inc. |
Formulations comprenant de l'ibrutinib
|
US9572811B2
(en)
|
2012-08-03 |
2017-02-21 |
Principia Biopharma Inc. |
Treatment of dry eye
|
ES2731833T3
(es)
|
2012-09-10 |
2019-11-19 |
Principia Biopharma Inc |
Compuestos pirazolopirimidínicos comos inhibidores de cinasas
|
JP6178861B2
(ja)
|
2012-11-02 |
2017-08-09 |
ファイザー・インク |
ブルトン型チロシンキナーゼ阻害剤
|
MX2015006168A
(es)
|
2012-11-15 |
2015-08-10 |
Pharmacyclics Inc |
Compuestos de pirrolopirimidina como inhibidores de quinasas.
|
US20140142099A1
(en)
|
2012-11-20 |
2014-05-22 |
Principia Biopharma Inc. |
Purinone Derivatives as Tyrosine Kinase Inhibitors
|
JO3377B1
(ar)
*
|
2013-03-11 |
2019-03-13 |
Takeda Pharmaceuticals Co |
مشتقات بيريدينيل وبيريدينيل مندمج
|
US8957080B2
(en)
*
|
2013-04-09 |
2015-02-17 |
Principia Biopharma Inc. |
Tyrosine kinase inhibitors
|
EA201691302A1
(ru)
|
2014-02-03 |
2017-03-31 |
Кадила Хелзкэр Лимитед |
Новые гетероциклические соединения
|
SG11201606858RA
(en)
|
2014-02-21 |
2016-09-29 |
Principia Biopharma Inc |
Salts and solid form of a btk inhibitor
|
MA41197B1
(fr)
|
2014-12-18 |
2021-01-29 |
Principia Biopharma Inc |
Traitement de le pemphigus
|
MA41256B1
(fr)
|
2014-12-24 |
2021-02-26 |
Principia Biopharma Inc |
Dosage spécifique de site d'un inhibiteur de btk
|
DK3236943T3
(da)
|
2014-12-24 |
2023-04-11 |
Principia Biopharma Inc |
Sammensætninger til ileo-jejunal lægemiddeladministration
|
HUE055419T2
(hu)
|
2015-06-03 |
2021-11-29 |
Principia Biopharma Inc |
Tirozinkináz-inhibitorok
|
US20180305350A1
(en)
|
2015-06-24 |
2018-10-25 |
Principia Biopharma Inc. |
Tyrosine kinase inhibitors
|
CN105753863B
(zh)
|
2015-09-11 |
2018-07-31 |
东莞市真兴贝特医药技术有限公司 |
氧代二氢咪唑并吡啶类化合物及其应用
|
WO2017066014A1
(fr)
|
2015-10-14 |
2017-04-20 |
Sunnylife Pharma Inc. |
Inhibiteurs de la tyrosine kinase de bruton
|
IL263815B
(en)
|
2016-06-29 |
2022-07-01 |
Principia Biopharma Inc |
Modified release formulations of 2-[3-[4-amino-3-(2-fluoro-4-phenoxy-phenyl)pyrazolo[4,3-d]pyrimidin-1-yl]piperidine-1-carbonyl]-4 -Methyl-4-[4-(Oxtan-3-yl)piperazin-1-yl)pent-2-ananitrile
|